A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

This revelation could cut addiction-related deaths by 50 percent. As scientists unravel the link between GLP-1 medications and addiction, it may hold clues for the development a drug that can treat ...

Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 medications may also fight addiction, says Dr. Ziyad Al-Aly whose team researched trends from GLP-1 use in 600,000 people ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce the tragic outcomes they cause, a large new study ...

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) receptor ...

Ziyad Al-Aly receives funding from U.S. Department of Veterans Affairs. A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his ...

Mary started drinking regularly in the early nineties, when she was thirteen. Her father had recently married a Danish woman and moved the family to Denmark, which has one of the highest teen-drinking ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Ziyad Al-Aly, Washington University in St. Louis (THE CONVERSATION) A patient of mine, ...